We are live on
!
Find out more
B
Braidwell Portfolio holdings
AUM
$3B
1-Year Est. Return
46.72%
This Fund
S&P 500
This Quarter
Est. Return
+2.32%
1 Year Est. Return
+46.72%
3 Year Est. Return
+56.07%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$2.92B
AUM Growth
+$79.1M
(+2.8%)
Cap. Flow
-$811M
Cap. Flow
% of AUM
-27.73%
Top 10 Holdings %
Top 10 Hldgs %
45.84%
Holding
71
New
6
Increased
13
Reduced
17
Closed
13
Top Buys
| 1 |
CAI
Caris Life Sciences
CAI
|
+$197M |
| 2 |
Krystal Biotech
KRYS
|
+$48M |
| 3 |
Edgewise Therapeutics
EWTX
|
+$39.7M |
| 4 |
Inspire Medical Systems
INSP
|
+$31.9M |
| 5 |
Xenon Pharmaceuticals
XENE
|
+$29.2M |
Top Sells
| 1 |
Transmedics
TMDX
|
+$65.9M |
| 2 |
BPMC
Blueprint Medicines
BPMC
|
+$38.9M |
| 3 |
iRhythm Holdings
IRTC
|
+$33.1M |
| 4 |
BCAX
Bicara Therapeutics
BCAX
|
+$28.2M |
| 5 |
Kiniksa Pharmaceuticals
KNSA
|
+$21.9M |
Sector Composition
| 1 | Healthcare | 71.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Kiniksa Pharmaceuticals
KNSA
$4.75B
| $30.5M | 1.04% |
1,102,580
-860,329
| -44% | -$21.9M |
|
27
Harrow
HROW
$1.6B
| $26.6M | 0.91% |
872,246
-84,593
| -9% | -$2.27M |
|
28
OrthoPediatrics
KIDS
$507M
| $23.8M | 0.81% |
1,107,770
| – | – |
|
29
Maravai LifeSciences
MRVI
$1.04B
| $20.1M | 0.69% |
8,353,287
| – | – |
|
|
APLS
30
DELISTED
Apellis Pharmaceuticals
APLS
| $19.4M | 0.66% |
1,121,034
-531,300
| -32% | -$9.83M |
|
|
SION
31
Sionna Therapeutics
SION
$2B
| $18.8M | 0.64% |
+1,081,855
| New | +$14.2M |
|
32
Madrigal Pharmaceuticals
MDGL
$12.7B
| $18.4M | 0.63% |
60,781
+12,091
| +25% | +$3.6M |
|
33
Repligen
RGEN
$8.35B
| $18M | 0.61% |
144,556
+62,900
| +77% | +$8M |
|
|
ORKA
34
Oruka Therapeutics
ORKA
$5.23B
| $17.1M | 0.58% |
1,524,842
-47,584
| -3% | -$496K |
|
35
Castle Biosciences
CSTL
$729M
| $16.8M | 0.57% |
822,735
+457,488
| +125% | +$8.47M |
|
36
UnitedHealth
UNH
$380B
| $15.4M | 0.53% |
+49,400
| New | +$18.9M |
|
37
Globus Medical
GMED
$10.7B
| $14.6M | 0.5% |
+247,200
| New | +$16M |
|
|
DAWN
38
DELISTED
Day One Biopharmaceuticals
DAWN
| $14.2M | 0.49% |
2,181,598
-1,355,255
| -38% | -$9.32M |
|
39
Xencor
XNCR
$1.11B
| $13M | 0.45% |
1,655,690
| – | – |
|
40
Celcuity
CELC
$4.46B
| $11.8M | 0.4% |
884,306
| – | – |
|
|
CBIO
41
Crescent Biopharma
CBIO
$432M
| $4.22M | 0.14% |
+261,504
| New | +$5.53M |
|
42
Replimune Group
REPL
$813M
| $3.93M | 0.13% |
422,887
-1,038,939
| -71% | -$9.07M |
|
43
Zura Bio
ZURA
$512M
| $2.6M | 0.09% |
2,472,806
| – | – |
|
44
Pulmonx
LUNG
$60.8M
| $1.95M | 0.07% |
752,541
| – | – |
|
45
Surrozen
SRZN
$253M
| $1.25M | 0.04% |
+140,000
| New | +$1.28M |
|
46
Ascendis Pharma A/S
ASND
$17.6B
| – | – |
-106,713
| Closed | -$16.6M |
|
|
JBIO
47
Jade Biosciences
JBIO
$1.33B
| – | – |
-41,157
| Closed | -$3.62M |
|
|
BPMC
48
DELISTED
Blueprint Medicines
BPMC
| – | – |
-439,968
| Closed | -$38.9M |
|
49
Cullinan Oncology
CGEM
$1.1B
| – | – |
-980,773
| Closed | -$7.42M |
|
50
Dianthus Therapeutics
DNTH
$5.46B
| – | – |
-375,355
| Closed | -$6.81M |
|
Similar funds
NC
VVP
SP
DIG
ECP
PCM
ROTUOC
SM